PharmaLink Inc. and Recall Results, Inc. Announce Strategic Partnership to Enhance Drug Safety and Recall Efficiency
[Largo, FL] — PharmaLink Inc., a national leader in pharmaceutical reverse distribution, and Recall Results, a prominent provider of comprehensive recall management and support services, today announced a strategic partnership aimed at enhancing drug safety and recall efficiency in the pharmaceutical industry. This groundbreaking collaboration leverages PharmaLink Inc.’s expertise in pharmaceutical returns processing and Recall […]
Aurigene Pharmaceutical Services Limited, a global CRDMO, announces the opening of its biologics facility offering process development and clinical scale manufacturing capabilities
Hyderabad, India– June 03, 2024: Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed to serve customers with process & analytical development and small scale manufacturing of antibodies and other recombinant […]
Dr. Reddy’s Laboratories Announces the Appointment of Milan Kalawadia to CEO North America
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), today announced the appointment of Milan Kalawadia as Chief Executive Officer, North America, and member of the Management Council. As part of the Dr. Reddy’s senior leadership team, he will be […]
PHARMACISTS MUTUAL INSURANCE COMPANY ANNOUNCES CHANGES TO THE BOARD OF DIRECTORS; KIRK HAYES RETIRES AS BOARD CHAIR AFTER A DISTINGUISHED 55 YEARS ON THE BOARD, INCLUDING 23 YEARS AS CHAIR
Kirk Hayes retires as Board Chair after a distinguished 55 years on the Board, including 23 years as Chair Susan Sutter to Assume Board Chair Jill Link Elected to the Board Algona, IA (May 28, 2024) – Pharmacists Mutual Insurance Company today announced the retirement of Kirk Hayes as Board Chair of the company’s Board […]
Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation
FORT WORTH, Texas–(BUSINESS WIRE)– Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced continued support for the global charity Mercy Ships with the donation of solutions from the recently announced XT Amplify program. The largest non-governmental hospital fleet in the world, Mercy Ships travels to developing […]
Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK
– Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK) – Alvotech will be responsible for development and manufacture of the product HYDERABAD, INDIA & REYKJAVIK, ICELAND (May 21, 2024) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development […]
Omnicell Announces XT Amplify
Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System FORT WORTH, Texas–(BUSINESS WIRE)– Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care […]
SoftWriters Set to Host First-Ever AI Mastermind Cohort
This strategic meeting will gather some of the top minds on AI within LTC Pharmacy Pittsburgh, PA – May 7, 2024 – SoftWriters, the leading provider of pharmacy management software for long-term care (LTC) pharmacies, is proud to announce its first-ever AI Mastermind Cohort, scheduled to take place from May 21 to May 23, 2024, […]
Endo Launches Enhanced TruDelivery® Ready-to-Use Product Line and Platform
MALVERN, Pa., May 6, 2024 /PRNewswire/ — Endo, Inc. announced today that its Endo Injectable Solutions business unit launched its enhanced ready-to-use product line and platform, TruDelivery®, underscoring the company’s commitment to building its ready-to-administer and ready-to-use portfolio. “As the name suggests, TruDelivery delivers—without mixing, compounding, or diluting—so our customers can focus on quality patient […]
Dr. Reddy’s Laboratories announces the launch of Doxycycline Capsules, 40 mg* in the U.S.
Hyderabad India; May 3, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), today announced its launch of Doxycycline Capsules, 40 mg* in the U.S. market, a therapeutic generic equivalent of ORACEA® (doxycycline, USP) Capsules, 40 mg approved by the […]
